Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo.
BACKGROUND
Sodium hyaluronate has been used intraperitoneally to prevent postoperative adhesions. However, the effect of sodium hyaluronate on tumour growth and metastasis in vitro and in vivo is still unknown.


METHODS
Human colorectal tumour cell lines SW480, SW620 and SW707 were treated with sodium hyaluronate (10-500 microg/ml) and carboxymethylcellulose (0.125-1 per cent), and tumour cell proliferation and motility were determined in vitro. For the in vivo experiments male BD IX rats were randomized to a sodium hyaluronate group (n = 11; intraperitoneal administration of 0.5 x 10(6) DHD/K12 tumour cells and 5 ml 0.4 per cent sodium hyaluronate) or a phosphate-buffered saline group (n = 11; 0.5 x 10(6) DHD/K12 tumour cells and 5 ml phosphate-buffered saline intraperitoneally). Four weeks later the intraperitoneal tumour load was visualized directly.


RESULTS
In vitro sodium hyaluronate increased tumour cell proliferation and motility significantly. Sodium hyaluronate-induced tumour cell motility appeared to be CD44 receptor dependent, whereas sodium hyaluronate-induced tumour cell proliferation was CD44 receptor independent. In vivo there was a significantly higher total tumour nodule count in the peritoneal cavity of the sodium hyaluronate-treated group compared with the control (P = 0.016).


CONCLUSIONS
Sodium hyaluronate enhances tumour metastatic potential in vitro and in vivo, which suggests that use of sodium hyaluronate to prevent adhesions in colorectal cancer surgery may also potentiate intraperitoneal tumour growth. Presented to the Patey Prize Session of the Surgical Research Society and the annual scientific meeting of the Association of Surgeons of Great Britain and Ireland, Brighton, UK, 4-7 May 1999
Tan
B
B
Department of Academic Surgery, Cork University Hospital, University College Cork, Cork, Ireland.
Wang
J H
JH
Wu
Q D
QD
Kirwan
W O
WO
Redmond
H P
HP
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement; D015179:Colorectal Neoplasms / Q000473:pathology*; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism; D006820:Hyaluronic Acid / Q000009:adverse effects*; D008297:Male; D009362:Neoplasm Metastasis / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000473:pathology; D051381:Rats; D014407:Tumor Cells, Cultured / Q000187:drug effects
D018960:Hyaluronan Receptors; D006820:Hyaluronic Acid